Suppressive effect of pentoxifylline on natural killer cell activity; Experimental and clinical studies

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 3, 1999, Pages 228-234

  Nagy, Z ^a   Sipka, R ^a   Ocsovszki, I ^a   Balogh, A ^a   Mandi Y ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Apoptosis; Macroangiopathic patients; Natural killer; Pentoxifylline

Indexed keywords

CD56 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NATURAL KILLER CELL;

EID: 0033002359     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005346     Document Type: Article

References (32)

1. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Williems GM (1990) Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265:4923-4928
2. Arase H, Arase N, Saito T (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235-1238
3. Balázs C, Kiss E (1994) Immunological aspects of the effect of pentoxifylline (Trental). Acta Microbiol Immunol Hung 41: 121-126
4. Balázs C, Kiss E, Vámos Á, Molnár I, Nadir RF (1997) Immunomodulatory effect of pentoxyfilline on thyroid associated ophthalmopathy. (A pentoxifyllin immunmoduláns hatása Graves-ophthalmopathiában). Orv Hetil 138:2869-2874
5. Belloc F, Jaloustre C, Dumain P, Lacombre F, Lenoble M, Boisseau MR (1995) Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol 25:S71-S74
6. Berke G (1995) Unlocking the secrets of CTL and NK cells. Immunol Today 16:343-346
7. Böyum A (1968) Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21 [Suppl 97]:77-89
8. Brittenden J, Heys SD, Ross J, Eremin O (1996) Natural killer cells and cancer. Cancer 77:1226-1243
9. Chong AS-F, Boussy LA, Jiang XL, Lamas M, Graf LH Jr (1994) CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol 157:92-105
10. Clerici M, Piconi S, Balotta C, Trabattoni D, Capetti A, Fusi ML, Ruzzante S, Longhi R, Colombo MC, Moroni M, Milazzo F (1997) Pentoxifylline improves cell-mediated immunity and reduces Human Immunodeficiency Virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons. J Infect Dis 175: 1210-1215
11. Dettelbach HR, Aviado DM (1985) Clinical pharmacology of pentoxifylline with special reference to its hemorheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 25:8-26
12. Doherty GM, Jensen JC, Alexander HR, Buersh CM, Norton JA (1991) Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110:192-198
13. Ely H (1994) Is pentoxifylline the drug of the decade? J Am Acad Dermatol 30:639-642
14. Espevik T, Niessen-Meyer JA (1986) A highly sensitive cell line WEHI-164 for measuring cytotoxic factor/tumor necrosis factor. J Immunol Methods 95:99-105
15. Hammerschmidt DE, Kotasek D, McCarthy T, Huh P-W, Freyburger G, Vercelotti GM (1988) Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. J Lab Clin Med 122:254-261
16. Jayaprakash D, Kumar KS, Shivaji S, Seshagiri PB (1997) Pentoxifylline induces hyperactivation and acrosome reaction in spermatozoa of golden hamsters: changes in motility kinematics. Hum Reprod 12:2192-2199
17. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, Oers MH van (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:532-540
18. Lanier LL, Philips JH, Hackett J, Tutt M, Kumar V (1986) Natural killer cells: definition of a cell type rather than a function. J Immunol 137:2735-2739
19. Leenen D van, Poll T van der, Levi M, Cate H ten, Deventer SJH van, Hack CE, Aarden LA, Cate JW ten (1993) Pentoxifylline attenuates neutrophil activation in experimental endotoxaemia in chimpanzees. J Immunol 151:2318-2325
20. Mándi Y, Farkas G, Ocsovszky I, Nagy Z (1995) Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: beneficial effects in sepsis syndrome. Res Exp Med 195:297-307
21. Moretta A (1997) Molecular mechanisms in cell-mediated cytotoxicity. Cell 90:13-18
22. Nagy Z, Mándi Y (1998) Natural killer cell-mediated cytotoxicity against VERO target cells; the suppressive effect of pentoxifylline. Immunol Lett (in press)
23. Nagy Z, Mándi Y, Gyulai Z, Farkas G, Márton J, Balogh Á (1997) Beneficial effects of pentoxifylline in sepsis syndrome. In: Faist E (ed) The immune consequences of trauma, shock and sepsis. Monduzzi Editore, Bologna, pp 903-908
24. Neuner P, Klosner G, Pourmojib M, Knobler R, Schwarz T (1997) Pentoxifylline in vivo and in vitro down-regulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology 90:435-439
25. Oshimi Y, Oda S, Honda Y, Nagata S, Miyazaki S (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J Immunol 157:2909-2915
26. Poggesi L, Scarti L, Boddi M, Masotti G, Serneri GGN (1985) Pentoxifylline treatment in patients with occlusive peripheral arterial disease: circulatory changes and effects on prostaglandin synthesis. Angiology 36:628-637
27. Reed WR, DeGowin RL (1992) Suppressive effects of pentoxifylline on natural killer cell activity. J Lab Clin Med 119:763-771
28. Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438
29. Samlaska MCP, Winfield EA (1994) Pentoxifylline. J Am Acad Dermatol 30:603-621
30. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47:187-376
31. Vermes I, Haanen C, Steffensnakken H, Reutelingsperger C (1995) A novel assay for apoptosis - flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 184:39-51
32. Yokoyama WM (1995) Natural killer cell receptors. Curr Opin Immunol 7:110-120